Karyopharm Therapeutics
KPTI
#9480
Rank
HK$0.40 B
Marketcap
HK$47.09
Share price
8.01%
Change (1 day)
446.77%
Change (1 year)

EPS for Karyopharm Therapeutics (KPTI)

EPS in 2023 (TTM): -HK$10.34

According to Karyopharm Therapeutics 's latest financial reports the company's current EPS (TTM) is -HK$10.24. In 2022 the company made an earnings per share (EPS) of -HK$15.75 a decrease over its 2021 EPS that were of -HK$12.88.

EPS history for Karyopharm Therapeutics from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$10.34-34.36%
2022-HK$15.7522.29%
2021-HK$12.88-39.19%
2020-HK$21.18-15.48%
2019-HK$25.063.19%
2018-HK$24.2811.79%
2017-HK$21.72-4.44%
2016-HK$22.73-11.75%
2015-HK$25.7537.76%
2014-HK$18.69-74.5%
2013-HK$73.31

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
HK$14.13-238.01%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$30.80-400.76%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$23.06-325.17%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$2.20-121.46%๐Ÿ‡บ๐Ÿ‡ธ USA